Next Article in Journal
Modulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain n-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs
Next Article in Special Issue
Nutritional and Metabolic Derangements in Pancreatic Cancer and Pancreatic Resection
Previous Article in Journal
Dietary Protein in Older Adults: Adequate Daily Intake but Potential for Improved Distribution
Previous Article in Special Issue
Black‐Box Gastrointestinal Tract—Needs and Prospects of Gaining Insights of Fate of Fat, Protein, and Starch in Case of Exocrine Pancreatic Insufficiency by Using Fistulated Pigs
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Nutrients 2017, 9(3), 183; doi:10.3390/nu9030183

Pancreatic Exocrine Insufficiency in Pancreatic Cancer

Center for Digestive Diseases, Karolinska University Hospital, Stockholm SE-141 86, Sweden
*
Author to whom correspondence should be addressed.
Received: 21 December 2016 / Revised: 27 January 2017 / Accepted: 17 February 2017 / Published: 23 February 2017
(This article belongs to the Special Issue Nutrition and Pancreatic Health)
View Full-Text   |   Download PDF [877 KB, uploaded 23 February 2017]   |  

Abstract

Abstract: Cancer patients experience weight loss for a variety of reasons, commencing with the tumor’s metabolism (Warburg effect) and proceeding via cachexia to loss of appetite. In pancreatic cancer, several other factors are involved, including a loss of appetite with a particular aversion to meat and the incapacity of the pancreatic gland to function normally when a tumor is present in the pancreatic head. Pancreatic exocrine insufficiency is characterized by a deficiency of the enzymes secreted from the pancreas due to the obstructive tumor, resulting in maldigestion. This, in turn, contributes to malnutrition, specifically a lack of fat-soluble vitamins, antioxidants, and other micronutrients. Patients with pancreatic cancer and pancreatic exocrine insufficiency have, overall, an extremely poor prognosis with regard to surgical outcome and overall survival. Therefore, it is crucial to be aware of the mechanisms involved in the disease, to be able to diagnose pancreatic exocrine insufficiency early on, and to treat malnutrition appropriately, for example, with pancreatic enzymes. View Full-Text
Keywords: pancreatic exocrine insufficiency; pancreatic cancer; pancreatic surgery; malnutrition; vitamin pancreatic exocrine insufficiency; pancreatic cancer; pancreatic surgery; malnutrition; vitamin
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Vujasinovic, M.; Valente, R.; Del Chiaro, M.; Permert, J.; Löhr, J.-M. Pancreatic Exocrine Insufficiency in Pancreatic Cancer. Nutrients 2017, 9, 183.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top